Almonty, Wants

Almonty Wants a Second Listing and a Bigger Board — Its Balance Sheet Is the Reason

Published on 11/17/2026 at 20:01 | Editorial boerse-global.de
Almonty posts CAD 41.9M Q3 2026 revenue, up 382% year on year, alongside independent-director changes and a planned Korea Exchange listing.
Almonty, Wants, Second, Listing, Bigger, Board, Its, Balance, Sheet, Reason Illustration mit AI erstellt.

Almonty is asking the market to judge it on two fronts at once. On the same day the tungsten producer unveiled an independent-director reshuffle and a planned second listing on the Korea Exchange, its third-quarter 2026 figures landed with a 382% year-on-year revenue jump to CAD 41.9 million. The governance and capital-markets moves, in other words, are arriving alongside — not instead of — the operational story that has to justify them.

The board changes take effect immediately. Eugene Bae and Jim Rudyk join as independent directors, bringing backgrounds spanning diplomacy, finance, capital markets and corporate governance — a mix Almonty frames around its twin tasks of advancing operations and opening up a further capital market. David Hanick and Andrew Frazer step down on 31.12.2026, after which the board is slated to hold seven members, five of them independent. Neither departs entirely: Hanick stays on as General Counsel and Frazer as Executive Consultant.

That split — departing voices remaining in advisory roles while fresh names take on oversight — is the detail worth watching. It can pair continuity with critical distance, though whether it does depends on how the board actually works rather than how it looks on paper. An independent majority is a structural precondition for the next stage, not a substitute for operating results.

Korea Listing Is an Intention, Not a Milestone

The Korea Exchange ambition carries the same caveat. Trading on the Nasdaq under ALM is set to continue, and a Korean lead banker is to be appointed at short notice. But the second listing remains a plan, contingent on exchange and regulatory approvals, suitable market conditions and compliance with securities law. Almonty attaches no timetable. The groundwork may create additional capital-market presence; it does not yet deliver access.

Should investors sell immediately? Or is it worth buying Almonty?

The geographic logic is easy enough to follow, given that Sangdong sits at the center of the expansion. Still, a second exchange changes trading structure first — the economic progress has to come from the mine and its build-out.

Where the Numbers Stand

Those numbers have shifted the scale of the discussion. Revenue of CAD 41.9 million in Q3 2026 compares with a year-earlier figure that the 382% growth rate implies was a fraction of it. Adjusted EBITDA reached CAD 14.6 million, reversing a CAD 2.3 million loss on the same basis in the prior-year quarter. That adjusted measure is not net profit, a distinction that matters when weighing how durable the improvement is.

Sangdong began producing tungsten concentrate for the first time in September 2026. According to Almonty's corporate update of 12 November, more than 90% of Phase I output is locked into long-term offtake agreements — a genuine economic foundation for the ramp-up, though contracts do not operate a plant. How the company converts that contracted base into running production is the open question.

Phase II is designed to lift annual throughput capacity to as much as 1.2 million tonnes, with completion targeted for 2027. That date comes with strings: Almonty ties it to the operation of the first expansion stage and to market conditions.

Sponsored Research, Conditional Valuation

Diamond Equity Research, in a study published today, links the growth to a positive valuation view while anchoring it to execution. The firm sets a value of USD 18.40 per share — explicitly conditional on the company's plans succeeding, and therefore a contingent assessment rather than an achieved enterprise value.

Almonty at a turning point? This analysis reveals what investors need to know now.

Investors should note who commissioned the work. Almonty paid for the analysis, which is expressly categorized as sponsored research. Diamond Equity Research has received USD 100,000 in total to date, with annual compensation of USD 50,000. The operational disclosures and the valuation built on them are best read separately.

What the study ultimately underscores is less the price target than the pairing of a sharp revenue increase with positive adjusted operating earnings. Turning that into sustained growth rests on the Sangdong ramp-up and on delivering the expansion now on the drawing board — the same execution test the board and the Korean listing will be measured against.

Ad

Almonty Stock: New Analysis - 17 November

Fresh Almonty information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Almonty analysis...

Disclaimer...
en | CA0203987072 | ALMONTY | boerse | 70528459 |